| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.4 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |